Navigation Links
Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
Date:2/14/2008

QINGDAO, China, Feb. 14 /Xinhua-PRNewswire/ -- Shenzhen Beike Biotechnology Co., Ltd. ( http://www.beikebiotech.com ), the world leader in the use of umbilical cord stem cells to successfully treat a variety of illnesses, announced that Audrey Jones, the former Lord Mayor of Manchester, has returned today to the United Kingdom (UK) with significant improvement in her debilitating and life-threatening condition known as cerebellar atrophy. As the latest of the over 2500 patients Beike has treated to date, the former Lord Mayor's improvements in China have made her a strong advocate for stem cell applications and the treatments that Beike Biotech provides. Before becoming the first patient in Beike's brand new stem cell treatment facility in the eastern China seaport of Qingdao, Lord Mayor Jones' neurosurgeon specialist in the UK told her there was no treatment for her condition, no cure, and that she would increasingly lose control of her body movements and functions until she was dead within a few years. After an intensive five week combination stem cell and therapy treatment program at Beike, Audrey Jones left China with much greater strength, improved balance, and more endurance, allowing her to walk normally without a wheelchair for the first time in years. Upon arrival in the UK today, she walked off the plane under her own power into the arms of her waiting family. More details on former Lord Mayor of Manchester Audrey Jones and her significant improvements can be found on China's leading stem cell news website, China Stem Cell News ( http://www.stemcellschina.com ).

"In England, I was looking into a bleak future. I had lost all hope and was deeply depressed. When I heard about Beike and the ability to receive stem cells right away, I began to hope again, which means everything," said Audrey Jones. "After going through the full program, seeing my own improvement, and walking again, my hope has been restored. Now my whole life is ahead of me," she stated.

Audrey Jones was Manchester's first Liberal Democrat Lord Mayor from May 2003 to June 2004, and is now a Councillor in the Town Hall of Manchester city, where she was born, educated, and has lived all her life. Before her position as Lord Mayor, Audrey Jones was part owner and Director of the South Manchester Reporter newspaper, also authoring a book on the City's children during World War II entitled, "Farewell Manchester." Before coming to China, she had been using an electric wheelchair to get around Town Hall, needed to be carried up and down stairs by others, and had suffered from daily bouts of debilitating fatigue.

"I can't wait to just walk right in the door of Town Hall and prove to others that there really is hope out there," said Audrey Jones. "Some people think that China couldn't possibly be a leader in advanced medical treatments like stem cells, but it is. My specialist and others who don't understand how advanced China has become told me that it must be a scam, and to be careful because China is a backward country. After coming here, I realize that to think of China as backward betrays an incredible ignorance," said former Lord Mayor Jones.

Audrey Jones was treated at Beike Biotech's stem cell treatment center in Qingdao, the newest of four world-class Beike hospital facilities located in major cities across China. Qingdao is world famous as the home of Tsing-Tao beer and is the city where the 2008 Olympic Sailing Competition is to be held later this year. The new Qingdao facility can accommodate up to 30 patients with their families and boasts state-of-the-art therapy equipment with a highly trained nursing staff as well as a groundbreaking global medical team. It provides quality stem cells to patients through intravenous (IV) drip, direct injection into the spinal canal via lumbar puncture, as well as surgery whereby stem cells are directly applied to injured sections of the spinal cord.

"With such growing demand and rapid increase in patients coming to China for Beike stem cells, our newest facility in Qingdao comes just in time to help those that do not want to wait," said Dr. Sean Hu, Chairman of Beike Biotechnology Co., Ltd. "I am elated to have former Lord Mayor of Manchester as our first patient in Qingdao, and even more pleased to see her excellent improvement from our holistic treatment. Beike patients represent people of the highest integrity from all over the world and I am glad to see all of them receiving benefit from our stem cell treatments," he said.

About Beike Biotechnology Company Limited

Beike is a biotechnology company that was founded in July 2005 with capital from Beijing University, Hong Kong University of Science and Technology and Shenzhen City Hall when it commercialized stem cell technology that had been in research since 1999. As a private high-tech enterprise, it is dedicated to the clinical application of stem cell research. It is also supported with funds from the China State National Fund. The research and clinical work is a collaboration of Beijing University, Hong Kong University of Science and Technology, No. 3 Army Medical University, Zhongshan Medical University, Guiyang Medical College and Zhengzhou University.

For more information, please contact:

Kirshner Ross-Vaden,

VP -- Foreign Patient Relations,

Beike Biotechnology Company, Ltd.

Tel: +1-877-278-3623

Email: info@beikebiotech.com

Web: http://www.beikebiotech.com


'/>"/>
SOURCE Shenzhen Beike Biotechnology Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
2. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
3. Former Patent Office Solicitor and Judge Joins Rothwell Figg
4. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
7. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
8. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
9. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
10. Stem Cell Leader Beike Biotech and Chinas Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory
11. Tasker Products Installs Scalder Application at New Poultry Processors Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... SPRING, Md. and RESEARCH TRIANGLE ... Therapeutics Corporation (NASDAQ: UTHR ) announced today ... Executive Officer, of United Therapeutics will provide an overview ... Bank 41 st Annual Health Care Conference. ... 5, 2016, at 10:00 a.m. Eastern Time, and can ...
(Date:4/27/2016)... ... April 27, 2016 , ... ... has joined the company as an Expert Consultant. Mr. Clark was formerly ... and managing the development of small molecule monographs based on analytical methods. ...
(Date:4/27/2016)... ... April 27, 2016 , ... ... PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging) in existing third-party MRI ... testing novel treatments in small animal subjects. Simultaneous PET/MRI imaging offers a solution ...
(Date:4/27/2016)... , ... April 27, 2016 , ... Global Stem ... endorsement of an Asia-Pacific Symposium as other research and development initiatives for potential stem ... officials and top Global Stem Cells Group executives began meeting to establish a working ...
Breaking Biology Technology:
(Date:3/11/2016)... Germany , March 11, 2016 http://www.apimages.com ... - Cross reference: Picture is available at AP Images ( http://www.apimages.com ... from DERMALOG will be used to produce the new refugee identity ... other biometric innovations, at CeBIT in Hanover ... scanner from DERMALOG will be used to produce the new refugee ...
(Date:3/9/2016)... , March 9, 2016 This BCC ... future states of the RNA Sequencing (RNA Seq) market ... such as instruments, tools and reagents, data analysis, and ... various segments of the RNA-Sequencing market such as RNA-Sequencing ... Identify the main factors affecting each segment and forecast ...
(Date:3/3/2016)... 2016  FlexTech, a SEMI Strategic Association Partner, awarded ... & Development, Leadership in Education, and, in a category ... th year of the FLEXI Awards and the ... from past years . Judging was done on ... of criteria, by a panel of non-affiliated, independent, industry ...
Breaking Biology News(10 mins):